APA (7th ed.) Citation

Viardot, A., & Nagorsen, D. (2016). Phase 2 study of the bispecific T-cell engager (BiTE) antibody blinatumomab in relapsed/refractory diffuse large B-cell lymphoma. Blood, 127(11), . https://doi.org/10.1182/blood-2015-06-651380

Chicago Style (17th ed.) Citation

Viardot, Andreas, and Dirk Nagorsen. "Phase 2 Study of the Bispecific T-cell Engager (BiTE) Antibody Blinatumomab in Relapsed/refractory Diffuse Large B-cell Lymphoma." Blood 127, no. 11 (2016). https://doi.org/10.1182/blood-2015-06-651380.

MLA (9th ed.) Citation

Viardot, Andreas, and Dirk Nagorsen. "Phase 2 Study of the Bispecific T-cell Engager (BiTE) Antibody Blinatumomab in Relapsed/refractory Diffuse Large B-cell Lymphoma." Blood, vol. 127, no. 11, 2016, https://doi.org/10.1182/blood-2015-06-651380.